We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+0.67%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$92.7B
AUM Growth
-$2.56B
(-2.7%)
Cap. Flow
-$2.27B
Cap. Flow
% of AUM
-2.45%
Top 10 Holdings %
Top 10 Hldgs %
11.3%
Holding
2,349
New
134
Increased
942
Reduced
1,022
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$252M |
| 2 |
Adobe
ADBE
|
+$238M |
| 3 |
Walmart Inc
WMT
|
+$233M |
| 4 |
Skyworks Solutions
SWKS
|
+$221M |
| 5 |
Target
TGT
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$361M |
| 2 |
Edison International
EIX
|
+$303M |
| 3 |
eBay
EBAY
|
+$281M |
| 4 |
Stellantis
STLA
|
+$276M |
| 5 |
Lam Research
LRCX
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.01% |
| 2 | Financials | 14.19% |
| 3 | Healthcare | 13.79% |
| 4 | Consumer Discretionary | 13.78% |
| 5 | Industrials | 12.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Culp Inc
CULP
$44.1M
| $332K | ﹤0.01% |
10,878
-1,189
| -10% | -$36.3K |
|
2027
WD-40
WDFC
$3.15B
| $331K | ﹤0.01% |
2,515
| – | – |
|
2028
Workiva
WK
$3.54B
| $330K | ﹤0.01% |
+13,940
| New | +$321K |
|
2029
AptarGroup
ATR
$8.61B
| $326K | ﹤0.01% |
3,626
-104
| -3% | -$9.17K |
|
2030
MiMedx Group
MDXG
$633M
| $326K | ﹤0.01% |
46,720
| – | – |
|
|
ARII
2031
DELISTED
American Railcar Industries, Inc.
ARII
| $325K | ﹤0.01% |
8,696
| – | – |
|
|
BREW
2032
DELISTED
Craft Brew Alliance, Inc.
BREW
| $324K | ﹤0.01% |
17,401
-4,658
| -21% | -$88K |
|
|
ACBI
2033
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $321K | ﹤0.01% |
17,735
+509
| +3% | +$9K |
|
2034
Titan International
TWI
$475M
| $320K | ﹤0.01% |
25,352
-5,732
| -18% | -$74.5K |
|
|
APTS
2035
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $319K | ﹤0.01% |
22,449
| – | – |
|
|
TSRO
2036
DELISTED
TESARO, Inc.
TSRO
| $318K | ﹤0.01% |
5,565
-2,645
| -32% | -$170K |
|
|
NVRO
2037
DELISTED
NEVRO CORP.
NVRO
| $316K | ﹤0.01% |
3,642
-137
| -4% | -$11.1K |
|
2038
Fate Therapeutics
FATE
$326M
| $313K | ﹤0.01% |
+32,037
| New | +$307K |
|
2039
Gerdau
GGB
$9.7B
| $312K | ﹤0.01% |
84,347
| – | – |
|
2040
Intellia Therapeutics
NTLA
$1.67B
| $312K | ﹤0.01% |
+14,791
| New | +$364K |
|
|
RAVN
2041
DELISTED
Raven Industries Inc
RAVN
| $309K | ﹤0.01% |
8,805
| – | – |
|
2042
Curis
CRIS
$7.83M
| $306K | ﹤0.01% |
234
-87
| -27% | -$114K |
|
2043
iRhythm Holdings
IRTC
$4.2B
| $305K | ﹤0.01% |
+4,844
| New | +$300K |
|
2044
Travere Therapeutics
TVTX
$5.78B
| $305K | ﹤0.01% |
13,648
-27,158
| -67% | -$647K |
|
2045
Steris
STE
$23.1B
| $304K | ﹤0.01% |
+3,255
| New | +$296K |
|
|
CALY
2046
Callaway Golf Company
CALY
$3.14B
| $303K | ﹤0.01% |
18,538
-23,886
| -56% | -$364K |
|
2047
Ring Energy
REI
$339M
| $302K | ﹤0.01% |
21,031
-5,060
| -19% | -$73.6K |
|
|
ADMS
2048
DELISTED
Adamas Pharmaceuticals
ADMS
| $299K | ﹤0.01% |
12,504
+3,329
| +36% | +$105K |
|
2049
Ezcorp Inc
EZPW
$1.71B
| $295K | ﹤0.01% |
+22,318
| New | +$285K |
|
2050
Chefs' Warehouse
CHEF
$4.5B
| $294K | ﹤0.01% |
12,778
+2,090
| +20% | +$45K |
|
Similar funds
VGA
AQR Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, AQR Capital Management held 2,349 positions worth $92.7B, down 2.7% from $95.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
AQR Capital Management's Q1 2018 filing shows 134 new, 942 increased, 1,022 reduced and 134 closed positions. Its largest new stake was Invesco QQQ Trust: 503,399 shares worth $74.4M. The largest sale was Boeing, an estimated $361M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- AQR Capital Management's largest Q1 2018 buy was Invesco QQQ Trust: 503,399 shares worth $74.4M.
- AQR Capital Management added most to Estee Lauder in Q1 2018, an estimated $252M increase.
- AQR Capital Management's biggest Q1 2018 reduction was Boeing, cutting an estimated $361M.
- AQR Capital Management fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $94.9M.
- AQR Capital Management's ten largest holdings make up 11% of its $92.7B portfolio in Q1 2018.
- AQR Capital Management opened 134 new positions and closed 134 in Q1 2018.
- AQR Capital Management's portfolio value fell 2.7% quarter-over-quarter to $92.7B.
Based on AQR Capital Management's 13F filing for Q1 2018, filed 15 May 2018.